🤖 AI Summary
Overview
This episode explores Robert F. Kennedy Jr.'s push to address the overuse of antidepressants in the U.S., highlighting the challenges of deprescribing
— the process of tapering off psychiatric medications. The discussion delves into the medical, regulatory, and personal dimensions of this growing movement, as well as the broader implications for mental health care.
Notable Quotes
- I've known people, including members of my family, who've had a much worse time getting off SSRIs than getting off heroin.
— Robert F. Kennedy Jr., on the challenges of discontinuing antidepressants.
- Prescribers aren't putting the same amount of care and attention into landing the plane as taking off.
— Ellen Barry, on the lack of focus on deprescribing in psychiatry.
- I want to live in color, not black and white.
— Speaker 3, on the desire to rediscover their authentic self after years on antidepressants.
🧠 The Rise of Deprescribing
- Ellen Barry defines deprescribing as the careful tapering or reduction of psychiatric medications, a concept gaining traction among patients and policymakers.
- Online communities have long shared experiences and strategies for tapering off medications, but RFK Jr.'s advocacy has brought this issue to the federal level.
- RFK Jr. has proposed regulatory changes, including Medicare/Medicaid reimbursement for deprescribing support and the creation of expert panels to develop tapering guidelines.
💊 Overprescription and Its Consequences
- SSRIs, initially intended for short-term use, are now often prescribed for years, with the median duration being five years.
- Many patients report being prescribed antidepressants without discussions about long-term plans or potential withdrawal.
- Side effects like emotional numbness, sexual dysfunction, and diminished efficacy over time drive some patients to question their continued use.
📋 Medical Community's Response
- Psychiatrists are divided: some view RFK Jr.'s proposals as a threat to the credibility of psychiatric treatments, while others acknowledge the need for better deprescribing practices.
- A lack of long-term research on SSRIs complicates the conversation, as most studies focus on short-term efficacy.
- Doctors at the American Psychiatric Association conference expressed regret over not addressing deprescribing earlier in their careers.
🌐 The DIY Deprescribing Movement
- Many patients resort to self-guided tapering, using online forums like Surviving Antidepressants
to share detailed withdrawal protocols.
- Common withdrawal symptoms include brain zaps, insomnia, and emotional instability, which can be debilitating without medical supervision.
- Distrust in the medical system often leads patients to take matters into their own hands, further highlighting gaps in care.
⚖️ Balancing Access and Caution
- RFK Jr.'s push for deprescription raises concerns about inadvertently stigmatizing antidepressants, potentially deterring those who could benefit from them.
- Disparities in access to mental health care persist, with white Americans taking antidepressants at significantly higher rates than other racial groups.
- The challenge lies in promoting thoughtful deprescription without undermining the importance of treatment for those in need.
AI-generated content may not be accurate or complete and should not be relied upon as a sole source of truth.
📋 Episode Description
In his latest public health crusade, Robert F. Kennedy Jr., the health secretary, is asking why millions of Americans have been taking psychiatric drugs for far longer than ever intended.
In the process, he’s highlighting an open secret in medicine: that doctors are better at starting drug treatments than at stopping them, and that patients who want to end their treatment are increasingly taking matters into their own hands.
Ellen Barry, a mental health reporter, takes us inside the growing movement to “deprescribe.”
Guest: Ellen Barry, a reporter covering mental health for The New York Times.
Background reading: Some psychiatrists fear that Mr. Kennedy’s call to rein in the use of depression medications will drive patients away from care.
Photo: Darren Staples/Reuters
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.